Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
14.50
-0.09 (-0.62%)
At close: Aug 28, 2025, 4:00 PM
14.50
0.00 (0.00%)
After-hours: Aug 28, 2025, 4:11 PM EDT
Embecta Revenue
Embecta had revenue of $295.50M in the quarter ending June 30, 2025, with 8.44% growth. This brings the company's revenue in the last twelve months to $1.10B, down -1.47% year-over-year. In the fiscal year ending September 30, 2024, Embecta had annual revenue of $1.12B with 0.21% growth.
Revenue (ttm)
$1.10B
Revenue Growth
-1.47%
P/S Ratio
0.77
Revenue / Employee
$525,000
Employees
2,100
Market Cap
848.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 1.12B | 2.30M | 0.21% |
| Sep 30, 2023 | 1.12B | -8.70M | -0.77% |
| Sep 30, 2022 | 1.13B | -35.80M | -3.07% |
| Sep 30, 2021 | 1.17B | 79.80M | 7.35% |
| Sep 30, 2020 | 1.09B | -23.50M | -2.12% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
EMBC News
- 8 hours ago - Embecta: Strategic Reprioritization Holds Promise And Valuations Are Favorable - Seeking Alpha
- 1 day ago - embecta to Participate in Investor Events - GlobeNewsWire
- 20 days ago - Embecta Corp. (EMBC) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 20 days ago - embecta Announces Quarterly Cash Dividend - GlobeNewsWire
- 4 weeks ago - embecta to Report Fiscal Third Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day - GlobeNewsWire
- 3 months ago - Embecta: Not Nearly As Cheap As The 4x Forward P/E Ratio Would Imply - Seeking Alpha